Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 6 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| IN8BIO, INC. | 553,110 | reported | 17 Aug 2022 | tx 5+73,275 |
| Lantern Pharma Inc. | 371,950 | reported | 29 Nov 2023 | tx 7−495,348 |
| COGNITION THERAPEUTICS INC | 316,038 | reported | 15 Nov 2022 | tx 3+1,500,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 Nov 2023 | SALE | Lantern Pharma Inc. | 53,640 | 3.44 USD | |
| 29 Nov 2023 | SALE | Lantern Pharma Inc. | 91,708 | 3.44 USD | |
| 15 Nov 2022 | PURCHASE | COGNITION THERAPEUTICS INC | 1,141,030 | 1.20 USD | |
| 15 Nov 2022 | PURCHASE | COGNITION THERAPEUTICS INC | 174,700 | 1.20 USD | |
| 15 Nov 2022 | PURCHASE | COGNITION THERAPEUTICS INC | 184,270 | 1.20 USD | |
| 08 Nov 2022 | SALE | Lantern Pharma Inc. | 40,586 | 4.40 USD | |
| 08 Nov 2022 | SALE | Lantern Pharma Inc. | 132,575 | 4.40 USD | |
| 08 Nov 2022 | SALE | Lantern Pharma Inc. | 17,748 | 4.40 USD | |
| 08 Nov 2022 | SALE | Lantern Pharma Inc. | 58,711 | 4.40 USD | |
| 08 Nov 2022 | SALE | Lantern Pharma Inc. | 100,380 | 4.40 USD | |
| 17 Aug 2022 | PURCHASE | IN8BIO, INC. | 6,142 | 1.93 USD | |
| 17 Aug 2022 | PURCHASE | IN8BIO, INC. | 5,823 | 1.93 USD | |
| 17 Aug 2022 | PURCHASE | IN8BIO, INC. | 38,035 | 1.93 USD | |
| 13 Aug 2021 | OTHER | IN8BIO, INC. | 12,775 | 0.00 USD | deriv |
| 13 Aug 2021 | OTHER | IN8BIO, INC. | 10,500 | 0.00 USD | deriv |